1. Home
  2. RCEL vs MTLS Comparison

RCEL vs MTLS Comparison

Compare RCEL & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

N/A

Current Price

$16.88

Market Cap

403.3M

Sector

Health Care

ML Signal

N/A

Logo Materialise NV

MTLS

Materialise NV

N/A

Current Price

$6.74

Market Cap

431.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RCEL
MTLS
Founded
N/A
1990
Country
United States
Belgium
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
403.3M
431.6M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
RCEL
MTLS
Price
$16.88
$6.74
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
★ $13.26
$9.99
AVG Volume (30 Days)
★ 429.2K
245.3K
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 27.20
N/A
EPS
N/A
★ N/A
Revenue
★ $71,610,000.00
N/A
Revenue This Year
$24.33
$3.97
Revenue Next Year
$26.85
$5.95
P/E Ratio
★ N/A
$61.39
Revenue Growth
★ 11.45
N/A
52 Week Low
$3.22
$4.78
52 Week High
$16.90
$8.82

Technical Indicators

Market Signals
Indicator
RCEL
MTLS
Relative Strength Index (RSI) 67.16 33.64
Support Level $3.86 $6.37
Resistance Level $16.90 $6.94
Average True Range (ATR) 1.15 0.41
MACD -0.03 -0.17
Stochastic Oscillator 70.61 15.84

Price Performance

Historical Comparison
RCEL
MTLS

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

About MTLS Materialise NV

Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.

Share on Social Networks: